{
  "meta": {
    "timestamp": "2025-01-06T13:10:05.936032",
    "version": "1.0",
    "type": "search_analysis"
  },
  "companies": [
    {
      "company_name": "Oxford Nanopore Technologies PLC",
      "symbol": "ONTTF",
      "analysis": {
        "historical": {
          "risk_score": 65,
          "key_risks": [
            "Accuracy concerns in clinical diagnostics",
            "Intense competition from established players like Illumina",
            "Regulatory challenges in clinical applications",
            "Supply chain vulnerabilities due to global disruptions",
            "Negative P/E ratio indicating financial losses",
            "Stock volatility and investor sensitivity"
          ],
          "controversies": [
            "Criticism regarding the accuracy of nanopore sequencing",
            "Ethical considerations in clinical applications"
          ],
          "environmental_issues": [],
          "social_issues": [
            "Ethical concerns regarding health assessment and disease diagnosis"
          ],
          "governance_issues": [],
          "recommendation": "caution",
          "confidence_score": 80
        },
        "evidence": {
          "sources": [
            {
              "url": "",
              "title": "Investor centre - Oxford Nanopore Technologies",
              "snippet": "Oxford Nanopore has developed a new generation of nanopore-based sensing technology. Our first products enable the real-time, high-performance, accessible and scalable analysis of DNA and RNA. Our technology is used in more than 125 countries to understand the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses and ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616269+00:00",
              "published_date": null,
              "source_hash": "548c0aed199ed70b96fc5deba692d380"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies PLC | Reuters",
              "snippet": "Oxford Nanopore Technologies forecast higher 2022 and 2023 revenue for its life sciences division on Tuesday, as the British biotech firm expects a sharp boost from a long-term multi-million ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "retrieved_at": "2025-01-06T20:09:38.623650+00:00",
              "published_date": null,
              "source_hash": "0083f1f736b771b7ca8effcbe401df05"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc (ONTTF) - Stock Analysis",
              "snippet": "About ONTTF. Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616230+00:00",
              "published_date": null,
              "source_hash": "277f92273d5620df43ade6a22aaac9f3"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc - Half Year Trading Update",
              "snippet": "About Oxford Nanopore Technologies plc: Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616245+00:00",
              "published_date": null,
              "source_hash": "74dc2cd1a19c9c82585f9b6f28849f89"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc - London Calling Technology Update",
              "snippet": "Oxford Nanopore Technologies plc (LSE: ONT) (\"Oxford Nanopore\" or the \"Company\"), the company delivering a new generation of nanopore-based molecular sensing technology, presented breakthrough performance data and new platform updates at the Company's annual London Calling customer conference, held between 21 and 24 May 2024.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "retrieved_at": "2025-01-06T20:09:38.623689+00:00",
              "published_date": null,
              "source_hash": "2903af6fb1987b417aa0df6792b0f860"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc (LON: ONT) - Stock Analysis",
              "snippet": "About LON: ONT. Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:42.751662+00:00",
              "published_date": null,
              "source_hash": "5f670e33af79f2672739a70e375f6cfa"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies Plc",
              "snippet": "OXFORD NANOPORE TECHNOLOGIES PLC ONT Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals ... Regulatory news (RNS) Reports. Reports . Issuers and instruments; Primary markets; Secondary markets; Group statistics; New issues. New issues . Upcoming issues; Recent issues; FTSE ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "retrieved_at": "2025-01-06T20:09:38.623710+00:00",
              "published_date": null,
              "source_hash": "6110b9ca0a7be962155971e7345d6cfb"
            },
            {
              "url": "",
              "title": "OXFORD NANOPORE TECHNOLOGIES PLC - London Stock Exchange",
              "snippet": "Regulatory news (RNS) Reports. Reports . Issuers and instruments; Primary markets; Secondary markets; Group statistics; New issues. New issues . Upcoming issues; Recent issues; FTSE index values Market Data Risers and Fallers . Personal Investing. ... OXFORD NANOPORE TECHNOLOGIES PLC; OXFORD NANOPORE TECHNOLOGIES PLC. Share . 219k Views . Is ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "retrieved_at": "2025-01-06T20:09:38.623721+00:00",
              "published_date": null,
              "source_hash": "68734ee5c341a23638edbf379c44b3f0"
            },
            {
              "url": "",
              "title": "Liquid Biopsy Research Report 2025-2030 Including - GlobeNewswire",
              "snippet": "These elements highlight the main challenges and opportunities within the market, shaping the industry's trajectory. ... 6.8 ANGLE plc 6.9 Applied DNA Sciences ... 6.86 Oxford Nanopore ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "retrieved_at": "2025-01-06T20:09:38.623732+00:00",
              "published_date": null,
              "source_hash": "c738b6ffaae65a38fb1fb3fe66e2d129"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc (LON: ONT) Company Profile & Overview ...",
              "snippet": "Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616309+00:00",
              "published_date": null,
              "source_hash": "0313cb3ca6ef449e8beecb4789861971"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc (LON:ONT) Insider Purchases \u00a3150.52 in Stock",
              "snippet": "Oxford Nanopore Technologies plc has a 12-month low of GBX 85 ($1.07) and a 12-month high of GBX 212.59 ($2.68). The stock has a market cap of \u00a31.46 billion, a P/E ratio of -774.00 and a beta of ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:51.276523+00:00",
              "published_date": "2024-12-14T00:00:00+00:00",
              "source_hash": "f584da6ce923f76f13eed4aa7db6d62f"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Expands Share Capital and Voting Rights",
              "snippet": "offering stakeholders a revised denominator for interest notifications under regulatory guidelines. More about Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC operates in the ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "retrieved_at": "2025-01-06T20:09:41.031667+00:00",
              "published_date": "2025-01-02T16:02:00+00:00",
              "source_hash": "10d80f7130eae855fdd3360f65e6359d"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies (LON:ONT) Stock Price Down 10.2% - Here's What Happened",
              "snippet": "Shares of Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) fell 10.2% during mid-day trading on Tuesday . The stock traded as low as GBX 127 ($1.59) and last traded at GBX 128.50 ($1.61).",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:51.276605+00:00",
              "published_date": "2024-12-24T10:26:00+00:00",
              "source_hash": "d5ee2d7733492de1976661be8de865e8"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies Announces Share Incentive Plan for CFO",
              "snippet": "Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest announcement is out from Oxford Nanopore Technologies PLC ( (GB:ONT)). Oxford Nanopore Technologies ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "retrieved_at": "2025-01-06T20:09:41.031723+00:00",
              "published_date": "2024-12-11T15:02:00+00:00",
              "source_hash": "4ca7eef4c6662280c80ecbca0b2fe4b1"
            },
            {
              "url": "",
              "title": "Oxford Nanopore and UK Biobank To Create World's First Epigenetic Dataset Targeting the Causes of Cancer, Dementia, Complex Disease",
              "snippet": "Oxford Nanopore Technologies, announced a new collaboration ... The initiative could also pave the way for new clinical applications, including disease risk screening and more precise diagnostics to support early-stage disease detection, offering hope ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "retrieved_at": "2025-01-06T20:09:41.031745+00:00",
              "published_date": "2024-12-02T00:00:00+00:00",
              "source_hash": "9aa4d76c3695c360ad90809584c5f3fb"
            },
            {
              "url": "",
              "title": "Reports & presentations - Oxford Nanopore Technologies",
              "snippet": "Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:42.751512+00:00",
              "published_date": null,
              "source_hash": "d9a922b93fd6f470aff69912e827ef7a"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies - Wikipedia",
              "snippet": "Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products (including the portable DNA sequencer, MinION) for the direct, electronic analysis of single molecules. [2] [3] [4] It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[5]",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:42.751605+00:00",
              "published_date": null,
              "source_hash": "7d4068160e05adb45aa5d9c4a327095f"
            },
            {
              "url": "",
              "title": "ONT Shows New High-Accuracy, High-Output Chemistry",
              "snippet": "OXFORD, UK / ACCESSWIRE / March 30, 2022 / Oxford Nanopore Technologies plc: Summary: Latest chemistry enables 99.3% raw read accuracy at high data yields; new Kit 14 and flow cells containing R10.4.1 pore will be provided as an upgrade to the current Kit 12 chemistry and R10.4 pore, and eventually replace the R9 chemistry versions",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:42.751632+00:00",
              "published_date": null,
              "source_hash": "f172955d27e6ca024f1a334777074d43"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc - FY23 trading update",
              "snippet": "About Oxford Nanopore Technologies plc: Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616105+00:00",
              "published_date": null,
              "source_hash": "f19695baa7e459447c24632b46ce95a3"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc (ONT.L) - Yahoo Finance",
              "snippet": "Find the latest Oxford Nanopore Technologies plc (ONT.L) stock quote, history, news and other vital information to help you with your stock trading and investing.",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:42.751672+00:00",
              "published_date": null,
              "source_hash": "24f5b271c742a2dcb05e8cce42156ed4"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies PLC | Reuters",
              "snippet": "Oxford Nanopore Technologies soared 45% in its market debut on Thursday, marking London's biggest biotech listing in recent years and valuing the firm at almost 5 billion pounds ($6.84 billion).",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:42.751680+00:00",
              "published_date": null,
              "source_hash": "b6efda1919530147da9b3eeb5b0ec6fd"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies PLC, ONT:LSE summary - FT.com",
              "snippet": "Latest Oxford Nanopore Technologies PLC (ONT:LSE) share price with interactive charts, historical prices, ... Genome sequencing to yield new cancer treatments, UK study finds ... nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date ...",
              "domain": "",
              "source_type": "web",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:42.751690+00:00",
              "published_date": null,
              "source_hash": "f82da3582797262c537d4c4b399bcdff"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies plc (LON:ONT) Insider Purchases \u00a3150.52 in Stock",
              "snippet": "Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:45.230064+00:00",
              "published_date": "2024-12-14T00:00:00+00:00",
              "source_hash": "60b8c57029253dea741106f4508dd8fe"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Expands Share Capital and Voting Rights",
              "snippet": "More about Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC operates in the biotechnology industry, focusing on innovative DNA/RNA sequencing ... and the accuracy of their ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:45.230157+00:00",
              "published_date": "2025-01-02T16:02:00+00:00",
              "source_hash": "6a68d688431a299bc382b313cbaf2399"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies Ltd (ONT)",
              "snippet": "Oxford Nanopore Technologies (ONT) has reported a steady performance in its 2024 Half Year Interim Results, with CEO Gordon Sanghera confirming the company's alignment with...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:45.230181+00:00",
              "published_date": "2024-12-23T16:35:00+00:00",
              "source_hash": "12db81269b88849a390bc8cc7ed21164"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies Announces Share Incentive Plan for CFO",
              "snippet": "Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest announcement is out ...",
              "domain": "",
              "source_type": "news",
              "category": "ethical_social",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "retrieved_at": "2025-01-06T20:09:45.230202+00:00",
              "published_date": "2024-12-11T15:02:00+00:00",
              "source_hash": "a5216a4517d8917f5aab2ed094de6bb0"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies PLC | Reuters",
              "snippet": "The latest international Oxford Nanopore Technologies PLC news and views from Reuters - one of the world's largest news agencies ... Reuters Impact; COP29; Legal. ... Oxford Nanopore Technologies ...",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616214+00:00",
              "published_date": null,
              "source_hash": "a914aaf2c7e7ec8ca953e3063d8c42c9"
            },
            {
              "url": "",
              "title": "Reports & presentations - Oxford Nanopore Technologies",
              "snippet": "Annual Results for the year ended 31 December 2023. Management will host a virtual presentation at 12pm GMT / 7am ET. Webcast.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616257+00:00",
              "published_date": null,
              "source_hash": "2006c76477335eb9a3e9d2919df2bd49"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies - Wikipedia",
              "snippet": "Oxford Nanopore Technologies plc is a UK-based company which develops and sells nanopore sequencing products (including the portable DNA sequencer, MinION) for the direct, electronic analysis of single molecules. [2] [3] [4] It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. [5]",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616281+00:00",
              "published_date": null,
              "source_hash": "9d87d6f6538cf846efc8cc087d118e79"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies PLC, ONT:LSE summary - FT.com",
              "snippet": "On Friday, Oxford Nanopore Technologies PLC (ONT:LSE) closed at 131.00, 54.12% above the 52 week low of 85.00 set on Jun 27, 2024. 52-week range. Today. ... Explore the time value of money, the impact of regular contributions, and the power of saving over longer timeframes. Alerts.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616296+00:00",
              "published_date": null,
              "source_hash": "1c860eeb3752eb06aec60e0cf1965536"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies - AnnualReports.com",
              "snippet": "Oxford Nanopore was founded in 2005 to develop a disruptive, electronic, single-molecule sensing system based on nanopore science. Their goal is to enable the analysis of anything, anywhere, by anyone. They have developed the world's first and only nanopore DNA and RNA sequencing platform.",
              "domain": "",
              "source_type": "web",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:48.616321+00:00",
              "published_date": null,
              "source_hash": "9926b4bbdd171a5d8f5122a103a5ad7c"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Technologies Announces Share Incentive Plan for CFO",
              "snippet": "which may positively impact its operational motivation and retention strategies. More about Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC operates in the biotechnology industry ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:51.276635+00:00",
              "published_date": "2024-12-11T15:02:00+00:00",
              "source_hash": "40ffd15157708310698c54155a886119"
            },
            {
              "url": "",
              "title": "Oxford Nanopore Expands Share Capital and Voting Rights",
              "snippet": "Oxford Nanopore Technologies PLC announced the issuance of 125,356 ordinary shares as part of its share option plans and remuneration schemes, now listed on the London Stock Exchange. This ...",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:51.276660+00:00",
              "published_date": "2025-01-02T16:02:00+00:00",
              "source_hash": "0478b528f68c336fa05cbfe163a71099"
            },
            {
              "url": "",
              "title": "Oxford Nanopore teams up with UK Biobank on epigenetic dataset",
              "snippet": "(Alliance News) - Oxford Nanopore Technologies PLC on Wednesday said it is collaborating with UK Biobank for an \"epigenetic dataset targeting the causes of cancer, dementia, complex disease\".",
              "domain": "",
              "source_type": "news",
              "category": "financial_legal",
              "query_context": "Oxford Nanopore Technologies PLC Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "retrieved_at": "2025-01-06T20:09:51.276683+00:00",
              "published_date": "2024-11-27T11:09:00+00:00",
              "source_hash": "bd47a8d26357f11be1539ac0fab7ce86"
            }
          ],
          "queries": [
            {
              "category": "financial_legal",
              "query": "Oxford Nanopore Technologies PLC regulatory challenges clinical diagnostics",
              "rationale": "Investigate regulatory hurdles for clinical applications of nanopore sequencing technology",
              "priority": 1
            },
            {
              "category": "ethical_social",
              "query": "Oxford Nanopore Technologies PLC accuracy concerns nanopore sequencing",
              "rationale": "Explore user and expert concerns regarding the accuracy of ONT's sequencing technology in critical applications",
              "priority": 2
            },
            {
              "category": "financial_legal",
              "query": "Oxford Nanopore Technologies PLC supply chain disruptions impact",
              "rationale": "Assess the impact of global supply chain vulnerabilities on ONT's production and distribution capabilities",
              "priority": 3
            }
          ]
        },
        "categorization": {
          "product_issues": [],
          "conduct_issues": [],
          "tags": [],
          "patterns": {}
        }
      },
      "metadata": {
        "analysis_timestamp": "2025-01-06T13:10:05.936040",
        "data_confidence": 80,
        "pattern_confidence": null
      }
    }
  ]
}